Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.540
-0.025 (-1.60%)
At close: Aug 28, 2026, 4:00 PM EDT
1.550
+0.010 (0.65%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $5.49 million as of August 28, 2026. Its market cap has decreased by -80.73% in one year.
Market Cap
5.49M
Enterprise Value
3.11M
1-Year Change
-80.73%
Ranking
Category
Stock Price
$1.54
ChartMarket Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $5.49M, a decrease of -90.56%. That is a compound annual growth rate of -48.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 5.49M | -65.34% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.27M |
| Enveric Biosciences | 6.13M |
| Processa Pharmaceuticals | 5.75M |
| Liminatus Pharma | 5.68M |
| Kairos Pharma | 5.62M |
| PharmaCyte Biotech | 5.53M |
| Pulmatrix | 5.51M |
| Cardio Diagnostics Holdings | 5.45M |